KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy, in patients with relapsed/refractory mantle cell lymphoma: results from phase 2 of ZUMA-2

被引：0

作者：

Wang, M. ^{[1
]}

Munoz, J. ^{[2
]}

Goy, A. ^{[3
]}

Locke, F. ^{[4
]}

Jacobson, C. ^{[5
]}

Hill, B. ^{[6
]}

Timmerman, J. ^{[7
]}

Holmes, H. ^{[8
]}

Jaglowski, S. ^{[9
]}

Flinn, I. ^{[10
]}

McSweeney, P. ^{[11
]}

Miklos, D. ^{[12
]}

Pagel, J. ^{[13
]}

Kersten, M. J. ^{[14
,15
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Banner MD Anderson Canc Ctr, Gilbert, AZ USA

[3] John Theurer Canc Ctr, Hackensack, NJ USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Cleveland Clin Fdn, Cleveland, OH USA

[7] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[8] Texas Oncol, Dallas, TX USA

[9] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA

[10] Sarah Cannon Res Inst, Nashville, TN USA

[11] Colorado Blood Canc Inst, Denver, CO USA

[12] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[13] Swedish Canc Inst, Seattle, WA USA

[14] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands

[15] HOVON LLPC Lunenburg Lymphoma Phase III Consortiu, Lunenburg, Netherlands

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BSH2020-OR

引用

页码：28 / 29

页数：2

共 50 条

[1] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Results of the Phase 2 ZUMA-2 Study
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 20 - 21
[2] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed/refractory (R/R) Mantle Cell Lymphoma (MCL): Results from Phase 2 of ZUMA-2
Wang, Michael
Munoz, Javier
Goy, Andre
Locke, Frederick
Jacobson, Caron
Hill, Brian
Timmerman, John
Holmes, Houston
Jaglowski, Samantha
Flinn, Ian
McSweeney, Peter
Miklos, David
Pagel, John
Kersten, Marie Jose
Peng, Weimin
Zheng, Lianqing
Rossi, John
Jain, Rajul
Rao, Arati
Reagan, Patrick
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 41 - 43
[3] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results from Phase 2 of ZUMA-2
Wang, Michael
Munoz, Javier
Goy, Andre
Locke, Frederick L.
Jacobson, Caron A.
Hill, Brian T.
Timmerman, John M.
Holmes, Houston
Jaglowski, Samantha
Flinn, Ian W.
McSweeney, Peter A.
Miklos, David B.
Pagel, John M.
Kersten, Marie Jose
Peng, Weimin
Zheng, Lianqing
Rossi, John M.
Jain, Rajul K.
Rao, Arati V.
Reagan, Patrick M.
MOLECULAR THERAPY, 2020, 28 (04) : 573 - 573
[4] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results of the Phase 2 ZUMA-2 Study
Wang, Michael
Munoz, Javier
Goy, Andre
Locke, Frederick L.
Jacobson, Caron A.
Hill, Brian T.
Timmerman, John M.
Holmes, Houston
Jaglowski, Samantha
Flinn, Ian W.
McSweeney, Peter A.
Miklos, David B.
Pagel, John M.
Kersten, Marie Jose
Peng, Weimin
Zheng, Lianqing
Rossi, John M.
Jain, Rajul K.
Rao, Arati V.
Reagan, Patrick M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S1 - S1
[5] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study
Wang, Michael L.
Munoz, Javier
Goy, Andre
Locke, Frederick L.
Jacobson, Caron A.
Hill, Brian T.
Timmerman, John M.
Holmes, Houston
Jaglowski, Samantha
Flinn, Ian W.
McSweeney, Peter A.
Miklos, David B.
Pagel, John M.
Kersten, Marie Jose
Peng, Weimin
Zheng, Lianqing
Rossi, John M.
Jain, Rajul K.
Rao, Arati V.
Reagan, Patrick M.
BLOOD, 2019, 134
[6] ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Davids, Matthew S.
Kenderian, Saad S.
Flinn, Ian W.
Hill, Brian T.
Maris, Michael
Ghia, Paolo
Byrne, Michael
Bartlett, Nancy L.
Pagel, John M.
Zheng, Yan
Kanska, Justyna
Zhang, Wangshu
Masouleh, Behzad Kharabi
Granados, Enrique
Ibarz, Javier Pinilla
BLOOD, 2022, 140 : 7454 - 7456
[7] Updated Phase 1 Results of Zuma-3: Kte-X19, an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
GWierda, William
Bishop, Michael R.
Oluwole, Olalekan
Logan, Aaron C.
Baer, Maria R.
Donnellan, William B.
O'Dwyer, Kristen M.
Castro, Januario E.
Schiller, Gary J.
Holmes, Houston
Abedi, Mehrdad
Ghobadi, Armin
Arellano, Martha L.
Malone, Adriana K.
Pagel, John M.
Mardiros, Armen
Shen, Tong
Vezan, Remus
Jain, Rajul K.
Shah, Bijal D.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[8] Product Characteristics and Pharmacological Profile of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma in the Phase II Registrational ZUMA-2 Trial
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 4 - 6
[9] KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Wang, Michael
Munoz, Javier
Goy, Andre
Locke, Frederick L.
Jacobson, Caron A.
Hill, Brian T.
Timmerman, John M.
Holmes, Houston
Jaglowski, Samantha
Flinn, Ian W.
McSweeney, Peter A.
Miklos, David B.
Pagel, John M.
Kersten, Marie-Jose
Milpied, Noel
Fung, Henry
Topp, Max S.
Houot, Roch
Beitinjaneh, Amer
Peng, Weimin
Zheng, Lianqing
Rossi, John M.
Jain, Rajul K.
Rao, Arati V.
Reagan, Patrick M.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14): : 1331 - 1342
[10] KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
Shah, Bijal D.
Bishop, Michael R.
Oluwole, Olalekan O.
Logan, Aaron C.
Baer, Maria R.
Donnellan, William B.
O'Dwyer, Kristen M.
Holmes, Houston
Arellano, Martha L.
Ghobadi, Armin
Pagel, John M.
Lin, Yi
Cassaday, Ryan D.
Park, Jae H.
Abedi, Mehrdad
Castro, Januario E.
DeAngelo, Daniel J.
Malone, Adriana K.
Mawad, Raya
Schiller, Gary J.
Rossi, John M.
Bot, Adrian
Shen, Tong
Goyal, Lovely
Jain, Rajul K.
Vezan, Remus
Wierda, William G.
BLOOD, 2021, 138 (01) : 11 - 22

← 1 2 3 4 5 →